Elecard Boro is a professional software solution for real-time video stream health monitoring and Quality of Service (QoS) & Quality of Experience (QoE) tracking across distributed networks. Designed for broadcasters, OTT providers, and IPTV operators, Boro utilizes distributed software probes to instantly isolate quality degradation across the entire delivery chain.
How it works:
Probes analyze UDP, RTP, HTTP, HLS, DASH, SRT, and RTMP streams up to UHD. Multi-point measurements are aggregated on a centralized server, providing instant alerts for ETSI TR 101 290 errors via Email, SNMP, Webhook, PagerDuty, and Telegram.
Key Features:
• Rapid Start: Deploy probes on any hardware in 10–30 minutes
• Deep Diagnostics: Tracks 50+ QoS/QoE parameters, SCTE-35 ad cues, and captures PCAP streams
• Smart Dashboards: Visualizes service states and captures stream thumbnails
• Easy Integration: Access via an intuitive web interface and integrate using WebHook, SNMP, and ControlAPI
Learn more
Docmosis is a self-hosted or SaaS template-based document generation solution. Integrate with custom-built software applications or popular third-party apps using the API.
Create templates using MS Word or LibreOffice. Add plain-text placeholders to control: the insertion of text/images/tables; conditionally add/remove any content; perform calculations; loop over repeating data; format data/numbers and much more.
Used by customers in Finance, Health, Legal, Education, Government, HR, Insurance, Logistics, and Manufacturing to generate customized letters invoices, proposals, contracts, statements, reports and more.
Integrate with: Custom software built using Java, C#, Python, PHP, Ruby and more via a REST API; Low-code and no-code platforms like Appian, Bubble, Mendix, Outsystems; Third-party form builders or apps that can perform a webhook such as FormAssembly or Salesforce.
Learn more
NeuroBlu
Behavioral health is a fundamental and persistently overlooked aspect of overall health. Mental and substance use disorders impact a staggering 970 million people worldwide, with over US $1 trillion in global economic burden each year. Despite the skyrocketing crisis, progress has lagged behind other disease areas. Less than half of those living with major depression, the most widespread mental illness, reach remission on currently available treatments. Recent rising awareness has driven demand in a system unequipped to support the depth and breadth of need. There is a debilitating evidence gap that inhibits research and innovation, stemming from inherent limitations in behavioral health: complex disease etiologies, lack of quantifiable biomarkers, and institutional silos. Despite decades of research, we still do not know how to alleviate most behavioral health disorders.
Learn more
